BioNexus Gene Lab Corp. (BGLC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 7.33M |
| Enterprise Value | 5.13M |
| P/E Ratio | -1.26 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 1.23 |
| Price/Book Ratio | 0.49 |
| Enterprise/Revenue | 0.9 |
| Enterprise/EBITDA | -1.15 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.82 |
| Operating Margin | -0.83 |
| Return On Assets | -0.3 |
| Return On Equity | -0.33 |
| Revenue | 7.42M |
| Revenue/Share | 1.29 |
| Gross Profit | 1.09M |
| EBITDA | -2.8M |
| Net Income | -2.98M |
| Diluted EPS | -1.61 |
| Total Cash | 3.52M |
| Total Cash/Share | 1.46 |
| Total Debt | 198,585 |
| Total Debt/Equity | 0.03 |
| Current Ratio | 6.08 |
| Book Value Per Share | 3.22 |
| 52-Week Change | -71.81 |
| 52-Week High | 6.1 |
| 52-Week Low | 1.07 |
| Moving Average 50 Days | 1.79 |
| Moving Average 200 Days | 2.7 |
| Average Volume | 104,208 |
| Shares Outstanding | 2.42M |
| % Held by Institutions | 0.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | April 07, 2025 |